Literature DB >> 3698035

Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.

J H von Roenn, S M Kheir, J M Wolter, J S Coon.   

Abstract

DNA ploidy of melanocytic skin tumors from 87 patients (53 primary melanomas, 34 nevi) was determined by flow cytometry from routinely prepared paraffin blocks. Ploidy data correlated strongly with conventional morphological parameters. Only 1 of 34 nevi, but 13 of 53 melanomas were aneuploid. Among the melanomas, none of 21 levels I-III melanomas was aneuploid, but 13 of 32 levels IV and V melanomas were aneuploid. There was also a significant correlation between increasing Breslow thickness and the presence of DNA aneuploidy. For 33 melanoma patients with over 2 yr of follow-up (average, 7.1 yr), only 4 of 23 diploid tumors have recurred, but 9 of 10 aneuploid tumors have recurred. We conclude that the biological potential of melanocytic skin tumors is strongly linked to DNA aneuploidy. Since this parameter can be conveniently determined from paraffin blocks, determination of ploidy abnormalities in these tumors may be clinically useful.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  DNA content and MHC class II antigen expression in malignant melanoma: clinical course.

Authors:  J Zaloudik; M Moore; A K Ghosh; Z Mechl; A Rejthar
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

2.  Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.

Authors:  S M Kheir; S D Bines; J H Vonroenn; S J Soong; M M Urist; J S Coon
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

3.  Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytological evidence for a higher malignant potential of the former.

Authors:  H I Chi; Y Uyeda; Y Umebayashi; F Otsuka
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Surgical management and prognostic factors in patients with subungual melanoma.

Authors:  K M Heaton; A el-Naggar; L G Ensign; M I Ross; C M Balch
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

5.  DNA index and S phase fraction in uveal malignant melanomas.

Authors:  W G Hodge; A J Duclos; G Rocha; E Antecka; M G Baines; C Corriveau; S Brownstein; J Deschenes
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

6.  The flow cytometry of melanocytic skin lesions.

Authors:  J A Newton; R S Camplejohn; D H McGibbon
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

7.  Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

Authors:  T Muhonen; S Pyrhönen; A Laasonen; V M Wasenius; S Asko-Seljavaara; K Franssila; L Kangas
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

8.  DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

Authors:  T Muhonen; S Pyrhönen; A Laasonen; S Asko-Seljavaara; K Franssila
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

9.  Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

Authors:  J M Karjalainen; M J Eskelinen; S Nordling; P K Lipponen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.